4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000288
Director sold 28,000 shares at an average $80.82 ($2,262,848)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENDER JOSEPH H · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Sale : show line 1 in the form 10b5-1 | −20,571 | $80.67 | $1,659,362 | 43,464 | I |
| 2025-12-01 | Sale : show line 2 in the form 10b5-1 | −7,429 | $81.23 | $603,486 | 36,035 | I |
| Open-market sales · 28,000 sh · avg $80.82 · $2,262,848 | ||||||
Loading xslF345X05/edgardoc.xml…